ArticleSafety Profile of Mutant EGFR-TK Inhibitors in Advanced Non–Small Cell Lung Cancer: A Meta-analysisAuthor:Omar K. Abughanimeh, MDPublish date: August 15, 2022This meta-analysis showed that mutant epidermal growth factor receptor–tyrosine kinase inhibitors have an incidence of adverse effects that is less...Read More
